Safety and Efficacy Assessment of Autologous Bone-marrow Derived Adult Mesenchymal Stem Cell Therapy in Patients With Anoxic(or Hypoxic) Brain Injury Pilot Trial

NCT02210624 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Anoxic Brain Injury

Interventions

BIOLOGICAL: HYNR-CS inj.

Sponsor

Hyun Young Kim